"Designing Growth Strategies is in our DNA"

Bleeding Disorder Testing Market Size, Share, Growth & COVID-19 Impact Analysis, By Product Type (Reagents & Consumables and Instruments), By Indication (Hemophilia A, Hemophilia B, Von Willebrand Disease, Idiopathic Thrombocytopenic Purpura, and Others), By End-user (Hospitals & Clinics, Diagnostic Centers, and Others), and Regional Forecast, 2023-2030

Last Updated: February 17, 2025 | Format: PDF | Report ID: FBI106908

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of Bleeding Disorders, by Key Countries, 2022
    2. New Product Launches, By Key Players
    3. Technological Advancements in the Global Bleeding Disorders Testing Market
    4. Impact of COVID-19 on the Market
  5. Global Bleeding Disorders Testing Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Product Type
      1. Reagents & Consumables
      2. Instruments
    2. Market Analysis, Insights and Forecast – By Indication
      1. Hemophilia A
      2. Hemophilia B
      3. Von Willebrand Disease
      4. Idiopathic Thrombocytopenic Purpura (ITP)
      5. Others
    3. Market Analysis, Insights and Forecast – By End-user
      1. Hospitals & Clinics
      2. Diagnostic Centers
      3. Others
    4. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Rest of the World
  6. North America Bleeding Disorders Testing Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Product Type
      1. Reagents & Consumables
      2. Instruments
    2. Market Analysis, Insights and Forecast – By Indication
      1. Hemophilia A
      2. Hemophilia B
      3. Von Willebrand Disease
      4. Idiopathic Thrombocytopenic Purpura (ITP)
      5. Others
    3. Market Analysis, Insights and Forecast – By End-user
      1. Hospitals & Clinics
      2. Diagnostic Centers
      3. Others
    4. Market Analysis, Insights and Forecast – By Country
      1. U.S.
      2. Canada
  7. Europe Bleeding Disorders Testing Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Product Type
      1. Reagents & Consumables
      2. Instruments
    2. Market Analysis, Insights and Forecast – By Indication
      1. Hemophilia A
      2. Hemophilia B
      3. Von Willebrand Disease
      4. Idiopathic Thrombocytopenic Purpura (ITP)
      5. Others
    3. Market Analysis, Insights and Forecast – By End-user
      1. Hospitals & Clinics
      2. Diagnostic Centers
      3. Others
    4. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. U.K
      2. Germany
      3. France
      4. Spain
      5. Italy
      6. Scandinavia
      7. Rest of Europe
  8. Asia Pacific Bleeding Disorders Testing Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Product Type
      1. Reagents & Consumables
      2. Instruments
    2. Market Analysis, Insights and Forecast – By Indication
      1. Hemophilia A
      2. Hemophilia B
      3. Von Willebrand Disease
      4. Idiopathic Thrombocytopenic Purpura (ITP)
      5. Others
    3. Market Analysis, Insights and Forecast – By End-user
      1. Hospitals & Clinics
      2. Diagnostic Centers
      3. Others
    4. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. Japan
      2. China
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  9. Rest of the World Bleeding Disorders Testing Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Product Type
      1. Reagents & Consumables
      2. Instruments
    2. Market Analysis, Insights and Forecast – By Indication
      1. Hemophilia A
      2. Hemophilia B
      3. Von Willebrand Disease
      4. Idiopathic Thrombocytopenic Purpura (ITP)
      5. Others
    3. Market Analysis, Insights and Forecast – By End-user
      1. Hospitals & Clinics
      2. Diagnostic Centers
      3. Others
  10. Competitive Analysis
    1. Global Market Share Analysis (2022)
    2. Company Profiles
      1. Siemens Healthcare GmbH
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      2. F. Hoffmann-La Roche Ltd.
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      3. Thermo Fisher Scientific Inc.
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      4. Abbott Laboratories
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      5. Atlas Medical GmbH
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      6. HORIBA, Ltd.
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      7. Sysmex Corporation
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      8. HYPHEN BioMed
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      9. Precision BioLogic Incorporated
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      10. Other Players
Read Less

Figure 1: Global Bleeding Disorders Testing Market Revenue Breakdown (USD million, %) by Region, 2022 & 2030

Figure 2: Global Bleeding Disorders Testing Market Value Share (%), by Product Type, 2022 & 2030

Figure 3: Global Bleeding Disorders Testing Market Value Share (%), by Indication, 2022 & 2030

Figure 4: Global Bleeding Disorders Testing Market Value Share (%), by End-user, 2022 & 2030

Figure 5: Global Bleeding Disorders Testing Market Value (USD million), by Region, 2022 & 2030

Figure 6: North America Bleeding Disorders Testing Market Value (USD million), by Product Type, 2022 & 2030

Figure 7: North America Bleeding Disorders Testing Market Value Share (%), by Product Type, 2022

Figure 8: North America Bleeding Disorders Testing Market Value (USD million), by Indication, 2022 & 2030

Figure 9: North America Bleeding Disorders Testing Market Value Share (%), by Indication, 2022

Figure 10: North America Bleeding Disorders Testing Market Value (USD million), by End-user, 2022 & 2030

Figure 11: North America Bleeding Disorders Testing Market Value Share (%), by End-user, 2022

Figure 12: North America Bleeding Disorders Testing Market Value (USD million), By Country, 2022 & 2030

Figure 13: North America Bleeding Disorders Testing Market Value Share (%), By Country, 2022

Figure 14: Europe Bleeding Disorders Testing Market Value (USD million), by Product Type, 2022 & 2030

Figure 15: Europe Bleeding Disorders Testing Market Value Share (%), by Product Type, 2022

Figure 16: Europe Bleeding Disorders Testing Market Value (USD million), by Indication, 2022 & 2030

Figure 17: Europe Bleeding Disorders Testing Market Value Share (%), by Indication, 2022

Figure 18: Europe Bleeding Disorders Testing Market Value (USD million), by End-user, 2022 & 2030

Figure 19: Europe Bleeding Disorders Testing Market Value Share (%), by End-user, 2022

Figure 20: Europe Bleeding Disorders Testing Market Value (USD million), By Country/ Sub-region, 2022 & 2030

Figure 21: Europe Bleeding Disorders Testing Market Value Share (%), By Country/ Sub-region, 2022

Figure 22: Asia Pacific Bleeding Disorders Testing Market Value (USD million), by Product Type, 2022 & 2030

Figure 23: Asia Pacific Bleeding Disorders Testing Market Value Share (%), by Product Type, 2022

Figure 24: Asia Pacific Bleeding Disorders Testing Market Value (USD million), by Indication, 2022 & 2030

Figure 25: Asia Pacific Bleeding Disorders Testing Market Value Share (%), by Indication, 2022

Figure 26: Asia Pacific Bleeding Disorders Testing Market Value (USD million), by End-user, 2022 & 2030

Figure 27: Asia Pacific Bleeding Disorders Testing Market Value Share (%), by End-user, 2022

Figure 28: Asia Pacific Bleeding Disorders Testing Market Value (USD million), By Country/ Sub-region, 2022 & 2030

Figure 29: Asia Pacific Bleeding Disorders Testing Market Value Share (%), By Country/ Sub-region, 2022

Figure 30: Rest of the World Bleeding Disorders Testing Market Value (USD million), by Product Type, 2022 & 2030

Figure 31: Rest of the World Bleeding Disorders Testing Market Value Share (%), by Product Type, 2022

Figure 32: Rest of the World Bleeding Disorders Testing Market Value (USD million), by Indication, 2022 & 2030

Figure 33: Rest of the World Bleeding Disorders Testing Market Value Share (%), by Indication, 2022

Figure 34: Rest of the World Bleeding Disorders Testing Market Value (USD million), by End-user, 2022 & 2030

Figure 35: Rest of the World Bleeding Disorders Testing Market Value Share (%), by End-user, 2022

Figure 36: Global Bleeding Disorders Testing Market Share (%), By Company, 2022

Table 1: Global Bleeding Disorders Testing Market Revenue (USD million) Forecast, by Product Type, 2019-2030

Table 2: Global Bleeding Disorders Testing Market Revenue (USD million) Forecast, by Indication, 2019-2030

Table 3: Global Bleeding Disorders Testing Market Revenue (USD million) Forecast, by End-user, 2019-2030

Table 4: Global Bleeding Disorders Testing Market Revenue (USD million) Forecast, by Region, 2019-2030

Table 5: North America Bleeding Disorders Testing Market Revenue (USD million) Forecast, by Product Type, 2019-2030

Table 6: North America Bleeding Disorders Testing Market Revenue (USD million) Forecast, by Indication, 2019-2030

Table 7: North America Bleeding Disorders Testing Market Revenue (USD million) Forecast, by End-user, 2019-2030

Table 8: North America Bleeding Disorders Testing Market Revenue (USD million) Forecast, By Country, 2019-2030

Table 9: Europe Bleeding Disorders Testing Market Revenue (USD million) Forecast, by Product Type, 2019-2030

Table 10: Europe Bleeding Disorders Testing Market Revenue (USD million) Forecast, by Indication, 2019-2030

Table 11: Europe Bleeding Disorders Testing Market Revenue (USD million) Forecast, by End-user, 2019-2030

Table 12: Europe Bleeding Disorders Testing Market Revenue (USD million) Forecast, By Country/ Sub-region, 2019-2030

Table 13: Asia Pacific Bleeding Disorders Testing Market Revenue (USD million) Forecast, by Product Type, 2019-2030

Table 14: Asia Pacific Bleeding Disorders Testing Market Revenue (USD million) Forecast, by Indication, 2019-2030

Table 15: Asia Pacific Bleeding Disorders Testing Market Revenue (USD million) Forecast, by End-user, 2019-2030

Table 16: Asia Pacific Bleeding Disorders Testing Market Revenue (USD million) Forecast, By Country/ Sub-region, 2019-2030

Table 17: Rest of the World Bleeding Disorders Testing Market Revenue (USD million) Forecast, by Product Type, 2019-2030

Table 18: Rest of the World Bleeding Disorders Testing Market Revenue (USD million) Forecast, by Indication, 2019-2030

Table 19: Rest of the World Bleeding Disorders Testing Market Revenue (USD million) Forecast, by End-user, 2019-2030

  • 2019-2030
  • 2022
  • 2019-2021
  • 130
Consulting Services
    How will you benefit from our consulting services ?